Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

SPRO Spero Therapeutics Inc

1,59

0,02 (1,27%)

18 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Spero Therapeutics (NASDAQ:SPRO)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Spero Therapeutics Charts.

Spero Therapeutics (NASDAQ:SPRO)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Spero Therapeutics Charts.

News Spero Therapeutics Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 15 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

U.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices Drop
Mittwoch 15 Mai 2024 (3 Tage vor) • IH Market News

Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
Mittwoch 6 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
Mittwoch 28 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference
Montag 26 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 9 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 5 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Spero Therapeutics Inc News-Artikel

NLBNPIT21MT4 20240918 5800

NLBNPIT1USI4 20991231 6....

NLBNPIT1UE28 20991231 35...

NLBNPIT20NM9 20240918 5500

Leverage Shares 3x Short...

NLBNPIT1UQH0 20991231 1....

NLBNPIT21SQ7 20240920 2500

NLBNPIT1XAN6 20351219 11...

NLBNPIT21043 20351219 50...

NLBNPIT20I28 20991231 20...

NLBNPIT1X0Z1 20240918 3500

EGR Exploration

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen